Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 20% ± 5% | |
epithelial cell | 5 studies | 24% ± 5% | |
glutamatergic neuron | 4 studies | 38% ± 10% | |
oligodendrocyte | 4 studies | 18% ± 2% | |
microglial cell | 3 studies | 17% ± 1% | |
GABAergic neuron | 3 studies | 35% ± 3% | |
dendritic cell | 3 studies | 21% ± 3% | |
transit amplifying cell | 3 studies | 23% ± 8% | |
astrocyte | 3 studies | 20% ± 3% | |
oligodendrocyte precursor cell | 3 studies | 23% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3101.47 | 1445 / 1445 | 100% | 21.79 | 183 / 183 |
intestine | 100% | 3373.52 | 966 / 966 | 100% | 24.62 | 527 / 527 |
lung | 100% | 3125.01 | 578 / 578 | 100% | 22.46 | 1155 / 1155 |
ovary | 100% | 4169.24 | 180 / 180 | 100% | 19.57 | 430 / 430 |
prostate | 100% | 3693.87 | 245 / 245 | 100% | 24.20 | 502 / 502 |
stomach | 100% | 2455.14 | 359 / 359 | 100% | 22.00 | 286 / 286 |
uterus | 100% | 4412.02 | 170 / 170 | 100% | 26.61 | 459 / 459 |
breast | 100% | 3489.69 | 459 / 459 | 100% | 25.04 | 1117 / 1118 |
bladder | 100% | 3436.19 | 21 / 21 | 100% | 22.87 | 503 / 504 |
skin | 100% | 4291.10 | 1809 / 1809 | 100% | 25.81 | 471 / 472 |
brain | 100% | 2911.04 | 2634 / 2642 | 100% | 28.22 | 705 / 705 |
thymus | 100% | 3806.32 | 653 / 653 | 100% | 25.11 | 602 / 605 |
kidney | 100% | 2469.85 | 89 / 89 | 99% | 18.73 | 896 / 901 |
adrenal gland | 100% | 3250.72 | 258 / 258 | 99% | 20.92 | 228 / 230 |
pancreas | 100% | 1630.84 | 327 / 328 | 99% | 20.16 | 176 / 178 |
liver | 100% | 1658.00 | 226 / 226 | 96% | 11.80 | 390 / 406 |
adipose | 100% | 3168.83 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3227.26 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 33.96 | 29 / 29 |
muscle | 100% | 2751.99 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4222.00 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 27.91 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.87 | 1 / 1 |
heart | 99% | 1877.63 | 853 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 18.70 | 79 / 80 |
peripheral blood | 91% | 2879.43 | 845 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010468 | Biological process | regulation of gene expression |
GO_0000244 | Biological process | spliceosomal tri-snRNP complex assembly |
GO_0140673 | Biological process | transcription elongation-coupled chromatin remodeling |
GO_0000387 | Biological process | spliceosomal snRNP assembly |
GO_0048872 | Biological process | homeostasis of number of cells |
GO_0071425 | Biological process | hematopoietic stem cell proliferation |
GO_0006334 | Biological process | nucleosome assembly |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0000902 | Biological process | cell morphogenesis |
GO_0046540 | Cellular component | U4/U6 x U5 tri-snRNP complex |
GO_0005691 | Cellular component | U6atac snRNP |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0071002 | Cellular component | U4atac/U6atac snRNP |
GO_0005737 | Cellular component | cytoplasm |
GO_0015030 | Cellular component | Cajal body |
GO_0071001 | Cellular component | U4/U6 snRNP |
GO_0061574 | Cellular component | ASAP complex |
GO_0005634 | Cellular component | nucleus |
GO_0042393 | Molecular function | histone binding |
GO_0030624 | Molecular function | U6atac snRNA binding |
GO_0017070 | Molecular function | U6 snRNA binding |
GO_0003723 | Molecular function | RNA binding |
GO_0030621 | Molecular function | U4 snRNA binding |
GO_0005515 | Molecular function | protein binding |
GO_1990381 | Molecular function | ubiquitin-specific protease binding |
Gene name | SART3 |
Protein name | Spliceosome associated factor 3, U4/U6 recycling protein Squamous cell carcinoma antigen recognized by T-cells 3 (SART-3) (Tat-interacting protein of 110 kDa) (Tip110) (p110 nuclear RNA-binding protein) |
Synonyms | KIAA0156 TIP110 |
Description | FUNCTION: U6 snRNP-binding protein that functions as a recycling factor of the splicing machinery. Promotes the initial reassembly of U4 and U6 snRNPs following their ejection from the spliceosome during its maturation . Also binds U6atac snRNPs and may function as a recycling factor for U4atac/U6atac spliceosomal snRNP, an initial step in the assembly of U12-type spliceosomal complex. The U12-type spliceosomal complex plays a role in the splicing of introns with non-canonical splice sites . May also function as a substrate-targeting factor for deubiquitinases like USP4 and USP15. Recruits USP4 to ubiquitinated PRPF3 within the U4/U5/U6 tri-snRNP complex, promoting PRPF3 deubiquitination and thereby regulating the spliceosome U4/U5/U6 tri-snRNP spliceosomal complex disassembly . May also recruit the deubiquitinase USP15 to histone H2B and mediate histone deubiquitination, thereby regulating gene expression and/or DNA repair . May play a role in hematopoiesis probably through transcription regulation of specific genes including MYC (By similarity). .; FUNCTION: Regulates Tat transactivation activity through direct interaction. May be a cellular factor for HIV-1 gene expression and viral replication. . |
Accessions | ENST00000546728.5 [Q15020-2] ENST00000651280.1 ENST00000547397.1 A0A494C0L2 ENST00000431469.6 [Q15020-4] ENST00000546611.1 [Q15020-3] A0A499FI31 ENST00000550619.1 F8W667 ENST00000547528.5 ENST00000546815.6 [Q15020-1] ENST00000550322.5 F8VZM2 Q15020 ENST00000228284.8 H0YHU8 F8VVK9 |